ITUB20156048A1 - Co-cristallo e forma amorfa di un farmaco antidiabetico - Google Patents
Co-cristallo e forma amorfa di un farmaco antidiabeticoInfo
- Publication number
- ITUB20156048A1 ITUB20156048A1 ITUB2015A006048A ITUB20156048A ITUB20156048A1 IT UB20156048 A1 ITUB20156048 A1 IT UB20156048A1 IT UB2015A006048 A ITUB2015A006048 A IT UB2015A006048A IT UB20156048 A ITUB20156048 A IT UB20156048A IT UB20156048 A1 ITUB20156048 A1 IT UB20156048A1
- Authority
- IT
- Italy
- Prior art keywords
- crystal
- amorphous form
- diabetic drug
- diabetic
- drug
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A006048A ITUB20156048A1 (it) | 2015-12-01 | 2015-12-01 | Co-cristallo e forma amorfa di un farmaco antidiabetico |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A006048A ITUB20156048A1 (it) | 2015-12-01 | 2015-12-01 | Co-cristallo e forma amorfa di un farmaco antidiabetico |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUB20156048A1 true ITUB20156048A1 (it) | 2017-06-01 |
Family
ID=55538451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUB2015A006048A ITUB20156048A1 (it) | 2015-12-01 | 2015-12-01 | Co-cristallo e forma amorfa di un farmaco antidiabetico |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITUB20156048A1 (it) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083066A2 (en) * | 2001-04-11 | 2002-10-24 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
US20110077212A1 (en) * | 2009-09-25 | 2011-03-31 | Theracos, Inc. | Therapeutic uses of sglt2 inhibitors |
US20140303096A1 (en) * | 2013-04-04 | 2014-10-09 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
-
2015
- 2015-12-01 IT ITUB2015A006048A patent/ITUB20156048A1/it unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083066A2 (en) * | 2001-04-11 | 2002-10-24 | Bristol-Myers Squibb Company | Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
US20110077212A1 (en) * | 2009-09-25 | 2011-03-31 | Theracos, Inc. | Therapeutic uses of sglt2 inhibitors |
US20140303096A1 (en) * | 2013-04-04 | 2014-10-09 | Boehringer Ingelheim Vetmedica Gmbh | Treatment of metabolic disorders in equine animals |
Non-Patent Citations (1)
Title |
---|
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3302565T3 (da) | Faste doseringsformer af palbociclib | |
DK3371171T3 (da) | Inhibitorer af RET | |
DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
DK3212230T3 (da) | Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer | |
DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
IL279949A (en) | Heterocyclic MCT4 inhibitors | |
DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
DE102016116153A8 (de) | Wirksame verfolgung von orten persönlicher vorrichtungen | |
GB201616211D0 (en) | Prediction of adverse drug events | |
DK3283210T3 (da) | Fremgangsmåde | |
DK3453721T3 (da) | Process of manufacture of annexin v | |
DK3164394T3 (da) | Gls1-inhibitorer til behandling af sygdomme | |
DK3132009T3 (da) | Fremgangsmåde | |
DK3149129T3 (da) | Anvendelse af imidazolholdige kvaternære ammoniumsalte | |
DK3204352T3 (da) | Hæmmere af lysin-gingipain | |
IT201600103091A1 (it) | Meccanismo di deviazione interattiva di pozzo di trivellazione | |
DK3285588T3 (da) | Fremgangsmåde | |
ITUB20156048A1 (it) | Co-cristallo e forma amorfa di un farmaco antidiabetico | |
DK3256107T3 (da) | Farmaceutisk formulering af racecadotril | |
IT201700068126A1 (it) | Struttura di filtropressa | |
IT201700010606A1 (it) | GenialCombi di Moscarelli | |
IT201600129753A1 (it) | Struttura di calcio-balilla | |
UA36698S (uk) | Набір форм для випікання |